Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Jacobson

Showing results (541-550 of 792) with videos related to

Pageof 80
Sort By:
Journal of Medicinal Chemistry|May 27, 2015
Structure-Activity Relationships of (+)-Naltrexone-Inspired Toll-like Receptor 4 (TLR4) AntagonistsBrandon R Selfridge, Xiaohui Wang, Yingning Zhang, et al.
Parkinsonism & Related Disorders|October 16, 2012
Impact of discontinuing tremor suppressing medications following thalamic deep brain stimulationChristopher G Favilla, Dan D Topiol, Theresa A Zesiewicz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 22, 2024
Harmonizing body surface area assessments between the Eczema Area and Severity Index, SCORing Atopic Dermatitis, and handprint methods utilizing one shared measurement-A proposal to improve efficiency and reduce error in atopic dermatitis trialsM E Jacobson, R S Seshadri, R Bissonnette, et al.
JAMA Dermatology|February 11, 2026
Development of a Patient Decision Aid for Atopic Dermatitis Systemic Treatments in AdultsRobyn Okereke, Wenelia Baghoomian, Rachel R Dunlap, et al.
Synapse (New York, N.Y.)|November 9, 2000
Opioid peptide receptor studies. 14. Stereochemistry determines agonist efficacy and intrinsic efficacy in the [(35)S]GTP-gamma-S functional binding assayH Xu, A Hashimoto, K C Rice, et al.
European Journal of Pharmacology|August 29, 1989
Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypesR B Rothman, C P France, V Bykov, et al.
Journal of Medicinal Chemistry|June 1, 1986
Probes for narcotic receptor mediated phenomena. 12. cis-(+)-3-Methylfentanyl isothiocyanate, a potent site-directed acylating agent for delta opioid receptors. Synthesis, absolute configuration, and receptor enantioselectivityT R Burke, A E Jacobson, K C Rice, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 27, 2021
Language Accessibility of Liver Transplantation Center WebsitesClare E Jacobson, Alisha Heximer, Robert Olmeda-Barrientos, et al.
European Journal of Orthopaedic Surgery & Traumatology : Orthopedie Traumatologie|March 1, 2022
Characterization of vitamin D deficiency and use of a standardized supplementation protocol in orthopaedic trauma patientsAndrew S Gudeman, Serena A Dine, Todd A Walroth, et al.
NIDA Research Monograph|January 1, 1989
In vivo binding of (+)-cis methylfentanyl at the opiate receptor complex and behavioral correlates: evidence for a novel mechanism of actionL Band, V Bykov, N Greig, et al.
Pageof 80

Showing results (541-550 of 792) with videos related to

Sort By:
Pageof 80
Journal of Medicinal Chemistry|May 27, 2015
Structure-Activity Relationships of (+)-Naltrexone-Inspired Toll-like Receptor 4 (TLR4) AntagonistsBrandon R Selfridge, Xiaohui Wang, Yingning Zhang, et al.
Parkinsonism & Related Disorders|October 16, 2012
Impact of discontinuing tremor suppressing medications following thalamic deep brain stimulationChristopher G Favilla, Dan D Topiol, Theresa A Zesiewicz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 22, 2024
Harmonizing body surface area assessments between the Eczema Area and Severity Index, SCORing Atopic Dermatitis, and handprint methods utilizing one shared measurement-A proposal to improve efficiency and reduce error in atopic dermatitis trialsM E Jacobson, R S Seshadri, R Bissonnette, et al.
JAMA Dermatology|February 11, 2026
Development of a Patient Decision Aid for Atopic Dermatitis Systemic Treatments in AdultsRobyn Okereke, Wenelia Baghoomian, Rachel R Dunlap, et al.
Synapse (New York, N.Y.)|November 9, 2000
Opioid peptide receptor studies. 14. Stereochemistry determines agonist efficacy and intrinsic efficacy in the [(35)S]GTP-gamma-S functional binding assayH Xu, A Hashimoto, K C Rice, et al.
European Journal of Pharmacology|August 29, 1989
Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypesR B Rothman, C P France, V Bykov, et al.
Journal of Medicinal Chemistry|June 1, 1986
Probes for narcotic receptor mediated phenomena. 12. cis-(+)-3-Methylfentanyl isothiocyanate, a potent site-directed acylating agent for delta opioid receptors. Synthesis, absolute configuration, and receptor enantioselectivityT R Burke, A E Jacobson, K C Rice, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 27, 2021
Language Accessibility of Liver Transplantation Center WebsitesClare E Jacobson, Alisha Heximer, Robert Olmeda-Barrientos, et al.
European Journal of Orthopaedic Surgery & Traumatology : Orthopedie Traumatologie|March 1, 2022
Characterization of vitamin D deficiency and use of a standardized supplementation protocol in orthopaedic trauma patientsAndrew S Gudeman, Serena A Dine, Todd A Walroth, et al.
NIDA Research Monograph|January 1, 1989
In vivo binding of (+)-cis methylfentanyl at the opiate receptor complex and behavioral correlates: evidence for a novel mechanism of actionL Band, V Bykov, N Greig, et al.
Pageof 80